Development of a Mobile Tool That Semiautomatically Screens Patients for Stroke Clinical Trials.
Despite several national coordinated research networks, enrollment in many cerebrovascular trials remains challenging. An electronic tool was needed that would improve the efficiency and efficacy of screening for multiple simultaneous acute clinical stroke trials by automating the evaluation of inclusion and exclusion criteria, improving screening procedures and streamlining the communication process between the stroke research coordinators and the stroke clinicians.



A multidisciplinary group consisting of physicians, study coordinators, and biostatisticians designed and developed an electronic clinical trial screening tool on a HIPAA (Health Insurance Portability and Accountability Act)-compliant platform.



A web-based tool was developed that uses branch logic to determine eligibility for simultaneously enrolling clinical trials and automatically notifies the study coordinator teams about eligible patients. After 12 weeks of use, 225 surveys were completed, and 51 patients were enrolled in acute stroke clinical trials. Compared with the 12 weeks before implementation of the tool, there was an increase in enrollment from 16.5% of patients screened to 23.4% of patients screened (P<0.05). Clinicians and coordinators reported increased satisfaction with the process and improved ease of screening.



We created a semiautomated electronic screening tool that uses branch logic to screen patients for stroke clinical trials. The tool has improved efficiency and efficacy of screening, and it could be adapted for use at other sites and in other medical fields.
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA. spokoyny@stanford.edu.
Ilana
I
Spokoyny
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Maarten
M
Lansberg
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Rosita
R
Thiessen
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Stephanie M
SM
Kemp
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Didem
D
Aksoy
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
YongJae
Y
Lee
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Michael
M
Mlynash
From the Stanford University Department of Neurology and Neurologic Sciences (I.S., M.L., K.G.H.); Stanford Stroke Center (R.T., S.M.K., D.A., M.M.); and Stanford Center for Clinical Informatics (Y.J.L.), Stanford, CA.
Karen G
KG
Hirsch
D002986:Clinical Trials as Topic / Q000191:economics*; D003362:Cost-Benefit Analysis; D004608:Eligibility Determination; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D018579:Patient Selection; D020521:Stroke / Q000628:therapy*
cerebral hemorrhage; clinical trials; cost-effectiveness; screening; stroke